transparent gif
AlzheimerSupport.com Home  
Functional Transitions and Active Life Expectancy Associated With Alzheimer Disease
Alzheimers Home Page Alzheimers Library Alzheimers Treatment and Research Email bulletins Alzheimers Products Alzheimers Community Area Alzheimers About Us transparent gif transparent gif
transparent gif
background The Latest News Articles background The Latest Abstracts background The Latest Drug News background
Search Our Site
 
 Alzheimers Info.
Alzheimers Resources

Your Support Funds Research & Advocacy

Functional Transitions and Active Life Expectancy Associated With Alzheimer Disease


alzheimersupport.com

02-24-2003

Advertisement
Hiroko H. Dodge, PhD; Changyu Shen, BS; Rajesh Pandav, MBBS, MPH; Steven T. DeKosky, MD; Mary Ganguli, MD, MPH

Context: The concept of active life expectancy, the number of years a person can expect to live without disability, is used for the first time, to our knowledge, to examine the effect of Alzheimer disease (AD) on total life expectancy with different degrees of disability.

Objectives: To estimate and compare total life expectancy and average duration lived with different degrees of disability, between persons with and without AD.

Design: Ten-year prospective epidemiologic study.

Setting: A largely blue-collar rural community in Southwestern Pennsylvania.

Participants: A population-based cohort of 1201 subjects (at the beginning of follow-up) with a mean age of 75 years.

Main Outcome Measures: At age 70 and every 2 years thereafter, among persons with AD and nondemented persons, (1) the total expectancy of remaining life and (2) the duration lived with different numbers of impaired instrumental activities of daily living (IADLs), grouped as 0 to 1, 2 to 5, and 6 to 7 impairments.

Results: Alzheimer disease greatly shortened the total life expectancy to a similar extent in men and women, with the most pronounced reduction among those who were younger. Besides their shorter survival, men and women with AD spent more absolute years, and also a greater proportion of their remaining lives, with 6 to 7 IADL impairments than did their nondemented age peers. Nondemented women spent more years with 2 to 5 IADL impairments than nondemented men, while women with AD spent more years with 6 to 7 IADL impairments than men with AD.

Conclusion: The concept of active life expectancy adds a useful new dimension to the study of outcomes in AD.

Arch Neurol. 2003;60:253-259

  Newsletter SignUp Discuss (0 comments) Email Article Print Page
Related Articles:
Effects of Rofecoxib or Naproxen vs Placebo on Alzheimer Disease Progression
Rating of 3
Memantine in Moderate-to-Severe Alzheimer's Disease
Rating of 3
Red wine micronutrients as protective agents in Alzheimer-like induced insult.
Rating of 3
Pulse Pressure and Risk of Alzheimer's Disease in Persons Aged 75 Years and Older: A Community-Based, Longitudinal Study
Rating of 2.9
Hormone replacement therapy in postmenopausal women with Alzheimer's disease: a randomized, prospective study.
Rating of 2.9

Every purchase funds research, donations and the community resources provided within our website.

Organic & pure - 100% acacia
RenewLife Clear Fiber

Buffered for easy absorption
Pro-C Complex™ 500mg

Our new proprietary energy NADH
Energy NADH™ 10 mg

Getting your daily supplements has never been easier!
Daily Health ProPack™

A detox your body will soak up!
Infinity Detox Brew BathTea Cream

At ProHealth we believe in "commerce with compassion."

Weekly Special





[ Be the first to comment on this article ]
DISCUSS THIS ARTICLE  (0 existing comments)
Post a Comment
transparent gif
transparent gif transparent gif transparent gif

Home | Library | Email Bulletins | Store | Community | Affiliates


ProHealth's AlzheimerSupport.com-
Email US or Call US at 1-800-366-6056
Monday-Friday, 7 a.m.-5 p.m. PST
International Callers can reach us at 001.805.564.3064
Copyright © 2008 ProHealth, Inc.
About us, Affiliates, Careers, Contact us, Privacy, 30-day Money Back Guarantee